About
Our Members
CENE members are professionals working in the innovation ecosystem who are Canadian or have experience living/working in Canada and have significant professional influence and connections that can be shared throughout CENE's programs. Not only is member interaction a key element to what CENE does, but our members are a core pillar that holds CENE up.
Learn about the different types of membership here.
A sample list of companies represented by our members include:
Allarta Life Science Inc, Analog Devices, Aruvant Sciences, Atorvia Health Tech, Banook Group, Barclay Damon LLP, Bausch + Lomb, Baylis Medical Company Inc., Boston Sales Solutions, Breathe BioMedical, Build In, Caldwell Intellectual Property Law, Champion, CIBC, Cordack CMC Consulting, Creliable, Damavand Consulting, Delix Therapeutics, Dewpoint Communications, Domain Therapeutics, Domus Diagnostics, Elucidus LLC, EmergConnect Inc., EverQuote, EY, Fibrogen Inc., Flagship Pioneering, Foley & Lardner, Great Dome Associates, Growthbridge Investments LLC, Harvard University, HLH Associates, Homecare Assistance, Innovactiv Inc., Insperity, International Business Development Consultant, Ipsen Biopharmaceuticals, JLL, Kebotix Inc., Keiretsu Forum New England, Ladybugz Interactive Agency, Lee Commercial Real Estate, Lumenix, M Squared Lasers, M&M Carnot, Mabel Systems, McGill Dobson Centre for Entrepreneurship, Merck & Co. Inc., Mersana Therapeutics, Naprico Inc., Ontario Bioscience Innovation Organization, Optimal Innovation Group Inc., OPTIMOULE, Precision Life Sciences, Priority Learning and Development Incorporated, Québec Government Office in Boston, QurCan, ReVive Advisors, Ring Therapeutics, Robinson & Cole LLP, RT Microdx, Rubin Rudman, Sanofi Pasteur, Schooner Capital, SmartLabs, Sonoscope, SpringWorks Therapeutics, Stiris Research, SVIS LLC, Takeda Pharmaceuticals, Tangent Capital, TD Bank, TEN DIGIT Communications LLC, Tenacity Engineering, The Rounds, Tidal Venture Partners, Toronto Global, True North Advisors Group LLC, Twist, Union.dev Software Inc., Vie Capital Partners, Zucara Therapeutics Inc.
